J, W., W, W., X, S., G, L., & X, W. (2022). Facing the CDK4/6i resistance dilemma in patients with breast cancer, exploration of the resistance mechanism and possible reverse strategy: A narrative review. Medicine, 101(51), e32238. https://doi.org/10.1097/MD.0000000000032238
Chicago Style (17th ed.) CitationJ, Wu, Wang W, Shao X, Lin G, and Wang X. "Facing the CDK4/6i Resistance Dilemma in Patients with Breast Cancer, Exploration of the Resistance Mechanism and Possible Reverse Strategy: A Narrative Review." Medicine 101, no. 51 (2022): e32238. https://doi.org/10.1097/MD.0000000000032238.
MLA (9th ed.) CitationJ, Wu, et al. "Facing the CDK4/6i Resistance Dilemma in Patients with Breast Cancer, Exploration of the Resistance Mechanism and Possible Reverse Strategy: A Narrative Review." Medicine, vol. 101, no. 51, 2022, p. e32238, https://doi.org/10.1097/MD.0000000000032238.